News about COVID-19's effects on stroke patients and stroke risk was Becker's most-read cardiology story in February.
The Latest
A dual-chamber leadless pacemaker system was implanted in the first U.S. patient as part of a global clinical trial at the Cleveland Clinic, the system said March 2.
Polycystic ovary syndrome is closely linked to heart and circulatory health, according to an Apple Women's Health Study released March 1.
Bacteria can attach and feed on cholesterol crystals, which can lead to the development of heart inflammation, a recent study published in PLOS ONE found.
Women with high blood pressure during pregnancy may face double the risk for kidney disease several years after giving birth, a study recently published in the journal Hypertension found.
The FDA Advisory Panel recommended Feb. 28 physicians conduct lifelong surveillance for abdominal aortic aneurysm patients who underwent endovascular aortic repair.
The FDA approved Eli Lilly's Jardiance to reduce the risk of cardiovascular death and hospitalization for heart failure in adults, the agency said Feb. 24.
Six cardiologists who recently joined new practices or stepped into new roles:
Multisystem inflammatory syndrome, or MIS-C, is rare in people ages 12 to 20 who are vaccinated against COVID-19, a study published Feb. 22 in The Lancet suggests.
Researchers at Los Angeles-based Cedars-Sinai's Smidt Heart Institute have created an artificial intelligence tool that can identify and distinguish between two overlooked heart conditions: hypertrophic cardiomyopathy and cardiac amyloidosis, the institute said Feb. 23.